Cleveland Clinic Laboratories

Size: px
Start display at page:

Download "Cleveland Clinic Laboratories"

Transcription

1 Cleveland Clinic Laboratories Technical Update July 2015 Cleveland Clinic Laboratories is dedicated to keeping you updated and informed about recent testing changes. That s why we are happy to provide this technical update on a monthly basis. Recently changed tests are bolded, and could include revisions to methodology, reference range, days performed or CPT code. For your convenience, tests are listed alphabetically and the order and billing codes are provided. If you wish to compare the new information with previous test information, refer to the Test Directory, which can be accessed at clevelandcliniclabs.com. Deleted tests and new tests are listed separately. Please update your database as necessary. For additional detail, contact Client Services at or or via at clientservices@ccf.org. Specimen Requirement Test Update Page # Special Information Test Discontinued New Test Name Change Billing Code Order Code Days Performed/Reported Reference Range Methodology Component Change Stability Summary of Changes by Test Name CPT Fee 3 Acyclovir 3 Alcohols 8 Alpha Globin (HBA1 & HBA2) Sequencing 9 Anti-HMGCR Autoantibodies 13 BCL 2 mbr (PCR) 3 Beta-2 Glycoprotein, IgG 3 Beta-2 Glycoprotein, IgM 9 Beta Globin (HBB) Gene Sequencing 3 Cardiolipin IgA Antibodies 3 Cardiolipin IgG Antibodies 3 Cardiolipin IgM Antibodies 3 Chromogranin A 3 Circulating Tumor Cells for Breast Cancer 4 Circulating Tumor Cells for Prostate Cancer 4 Cortisol Binding Globulin 4 DRPLA DNA Test 4 Fatty Acid Profile of Lipids 9 FISH for RET (10q11) 13 FISH for ROS1 (6q22) 4 Gliadin (Deamidated) IgA Antibody 9, 10 GlycoMark 13 HCV RNA bdna Quant with HCV Quant Reflex 9500 Euclid Avenue Cleveland, Ohio clevelandcliniclabs.com 1

2 Component Change Specimen Requirement Test Update Page # Special Information Test Discontinued Name Change Billing Code Order Code Days Performed/Reported Reference Range Methodology New Test Stability Summary of Changes by Test Name CPT Fee 4, 13 Iron, Urine 24 hours 4 Kappa, Free, Serum 5 Kappa/Lambda, Free, Serum 5 Kennedy's Disease DNA Test 5 L/S Ratio 5 Lambda, Free, Serum 5 Liver Kidney Microsome IgG Autoantibodies 13 LOH for 1p (PCR) 13 LOH for 19q 5 Lyme Western Blot 13 Maternal Cell Contamination, Integrated Genetics 6 Meperidine & Normeperidine 13 Methadone 10 Methadone & Metabolites 6 Myeloid Malignancy Mutation Panel by Next Generation Sequencing 6 Myeloperoxidase Autoantibodies 6 Natural Killer Cells, Functional 6 Neutrophil Cytoplasmic Antibody 10 Nitrogen, Total, Feces 6 Parvovirus B19 IgG Antibodies 6 Parvovirus B19 IgM Antibodies 11 Phospholipase A2 Receptor Antibody, IgG 13 PLA 1/2 by PCR 6 Proteinase 3 Autoantibodies 11 Retinal Dystrophy Panel 6 RPR 6 Synovial Fluid, Crystals ID and Staff Review 6 Synovial Fluid, Routine Analysis 7 Thiocyanate 7 Urticaria-Induced Basophil Activation 12 Uveal Melanoma, Prognostic 7 VIP 13 Vitamin D 25 Hydroxy 8 Y-Chromosome Microdeletion 9500 Euclid Avenue Cleveland, Ohio clevelandcliniclabs.com 2

3 Test Changes Test Name Order Code Billing Code Change Effective Date Acyclovir ACYCLO Methodology: High Performance Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS) Reference Range: Usual therapeutic range (vs. Genital Herpes) during chronic oral daily divided dosages of mg: Peak: µg/ml Trough: µg/ml CPT: Alcohols ALCOS Specimen Requirement: 2 ml serum in a red top tube; Minimum: 0.3 ml; Do not use serum separator tubes; Submit specimen in a tightly capped ARUP Standard Transport tube. Separate serum from cells within 2 hours of collection; *OR* 2 ml plasma from an EDTA lavender top tube; Minimum: 0.3 ml; Do not use plasma separator tubes; Submit specimen in a tightly capped ARUP Standard Transport tube. Separate plasma from cells within 2 hours of collection; *OR* 2 ml plasma from a potassium oxalate/sodium fluoride gray top tube; Minimum: 0.3 ml; Do not use plasma separator tubes; Specimens collected in this tube may be transported in the original container; Reference Range: Ethanol: No therapeutic range Assay detection limit: 5 mg/dl Therapy for Methanol: mg/dl Toxic: > 250 mg/dl Methanol: No therapeutic range Assay detection limit: 5 mg/dl; Toxic: > 20 mg/dl Isopropanol: No therapeutic range Assay detection limit: 5 mg/dl; Toxic: > 50 mg/dl Acetone, Quant: Therapeutic range: Not well established Assay detection limit: 5 mg/dl; Toxic: > 100 mg/dl Days Performed: Sunday Saturday Reported: 2 3 days CPT: G6040, /1/2015 7/16/2015 Beta-2 Glycoprotein, IgG Beta-2 Glycoprotein, IgM Cardiolipin IgA Antibodies Cardiolipin IgG Antibodies Cardiolipin IgM Antibodies BETA2G Days Performed: Monday Friday Reported: 1 3 days BETA2M Days Performed: Monday Friday Reported: 1 3 days CARDIA Days Performed: Monday Friday Reported: 1 3 days CARDIG Days Performed: Monday Friday Reported: 1 3 days CARDIM Days Performed: Monday Friday Reported: 1 3 days 6/15/2015 6/15/2015 6/15/2015 6/15/2015 6/15/2015 Chromogranin A CHROMA Specimen Requirement: 0.8 ml serum from a serum separator tube; Minimum: 0.3 ml; Frozen *OR* 0.8 ml serum from a red top tube; Minimum: 0.3 ml; Frozen Methodology: Electrochemiluminescence (ECLIA) Reference Range: 15 ng/ml Days Performed: Sunday Friday Reported: 4 6 days 7/13/2015 Circulating Tumor Cells for Breast Cancer CTC Effective 6/1/2015, this test is once again available as an orderable test. However on the test build will change for interfaced clients. 6/1/ Euclid Avenue Cleveland, Ohio clevelandcliniclabs.com 3

4 Test Changes (Cont.) Test Name Order Code Billing Code Change Effective Date Circulating Tumor Cells for Prostate Cancer Cortisol Binding Globulin CTCP Effective 6/1/2015, this test is once again available as an orderable test. However on the test build will change for interfaced clients. CBG Specimen Requirement: 0.5 ml serum from a serum separator tube; Minimum: 0.1 ml; Remove serum from cells within one hour of collection; Frozen *OR* 0.5 ml serum from a red top tube; Minimum: 0.1 ml; Remove serum from cells within one hour of collection; Frozen Ambient: 2 days : 2 days Frozen: 10 months Reference Range: Adult: mg/dl Pediatric: Not established Days Performed: Monday, Thursday Reported: 3 10 days 6/1/2015 6/4/2015 DRPLA DNA Test DRPLA For Interfaced Clients Only: Test build will need to be modified Special Information: Required forms may be obtained by contacting Client Services at (800) or (216) The Congenital Inherited Diseases Patient Information sheet may also be found at MC _Molecular_Genetics-Congenital_Inherited_Diseases_ Patient_Information.pdf. The informed consent form may also be found at mayomedicallaboratories.com/it-mmfiles/informed_consent_for_ Genetic_Testing.pdf Fatty Acid Profile of Lipids CFA Billing code: Previously /18/2015 Gliadin (Deamidated) IgA Antibody GLIIGA Days Performed: Monday Friday Iron, Urine 24 hours UFE For Interfaced Clients only: Test build will need to be modified Includes: Iron Total Volume Specimen Requirement: 10 ml urine in a clean container from a well-mixed 24 hour collection; Minimum: 6 ml; Refrigerate during collection; Transport container should not have a metal cap or glued insert; Ambient: 4 days : 14 days Frozen: 14 days Methodology: Inductively Coupled Plasma/Mass Spectrometry (ICP/MS) Days Performed: Tuesday Saturday Reported: 2 6 days Kappa, Free, Serum FKAPPS Ambient: 7 hours : 6 weeks Frozen: 1 year Methodology: Turbidimetry (TURB) Reference Range: mg/l Days Performed: Monday Friday 6/16/2015 9/9/ Euclid Avenue Cleveland, Ohio clevelandcliniclabs.com 4

5 Test Changes (Cont.) Test Name Order Code Billing Code Change Effective Date Kappa/Lambda, Free, Serum Kennedy's Disease DNA Test KLFRS Ambient: 7 hours : 6 weeks Frozen: 1 year Methodology: Turbidimetry (TURB) Reference Range: mg/l Days Performed: Monday Friday KENEDY For Interfaced Clients Only: Test build will need to be modified Special Information: The Informed Consent form may be obtained by contacting Client Services at or It may also be found at: The Molecular Genetics-Congenital Inherited Diseases Patient Information form may be obtained by contacting Client Services at or It may also be found at: www. mayomedicallaboratories.com/it-mmfiles/mc _molecular_ Genetics_Congenital_Inherited_Diseases_Patient_Information.pdf Clinical Information: Detects CAG triplet repeat expansion in the androgen receptor gene. CAUTIONS: For predictive testing, it is important to first document the presence of a CAG-repeat amplification in the androgen receptor (AR) gene in an affected family member to confirm that molecular expansion is the underlying mechanism of disease in the family. Predictive testing of an asymptomatic child is not recommended. A previous bone marrow transplant from an allogenic donor will interfere with testing. 9/9/2015 L/S Ratio LSRAT Special Information: Amniocentesis fluid preferred. Do not centrifuge. Vaginally obtained samples (vaginal pools) are not an acceptable specimen. If vaginal pool is received, test must be cancelled. Lambda, Free, Serum Liver Kidney Microsome IgG Autoantibodies FLAMBS Ambient: 7 hours : 6 weeks Frozen: 1 year Methodology: Turbidimetry (TURB) Days Performed: Monday Friday LKM Specimen Requirement: 0.5 ml serum from a serum separator tube; Frozen 9/9/2015 7/2/2015 Lyme Western Blot LYMEWB Days Performed: Tuesday, Friday 9500 Euclid Avenue Cleveland, Ohio clevelandcliniclabs.com 5

6 Test Changes (Cont.) Test Name Order Code Billing Code Change Effective Date Meperidine & Normeperidine Myeloid Malignancy Mutation Panel by Next Generation Sequencing Myeloperoxidase Autoantibodies Natural Killer Cells, Functional Neutrophil Cytoplasmic Antibody Parvovirus B19 IgG Antibodies Parvovirus B19 IgM Antibodies Proteinase 3 Autoantibodies MEPNO For Interfaced Clients only: Test build will need to be modified Includes: Meperidine Normeperidine Meperidine Dose Meperidine Route Meperidine Dose Frequency Meperidine Type of Draw Special Information: Please provide the following information: 1. Dose List drug amount and include the unit of measure 2. Route List the route of administration (IV, oral, etc.) 3. Dose Frequency Indicate how often the dose is administered (per day, per week, as needed, etc.) 4. Type of Draw Indicate the type of blood draw (Peak, Trough, Random, etc.) Days Performed: Tuesday, Thursday Reported: 2 7 days MYENGS Special Information: Includes: ASXL1, BCOR, BCORL1, BRAF, BRINP3, CALR, CBL, CEBPA, CSF3R, DNMT1, DNMT3A, EED, ETV6, EZH2, FLT3, GATA1, GATA2, HNRNPK, IDH1, IDH2, JAK2, JAK3, KDM6A, KIT, KMT2A, KRAS, LUC7L2, MPL, NOTCH1, NPM1, NRAS, NSD1, PHF6, PRPF40B, PTPN11, RAD21, RUNX1, SETBP1, SF1, SF3A1, SF3B1, SMC1A, SMC3, SRSF2, STAG2, SUZ12, TET1, TET2, TP53, U2AF1, U2AF2, WT1, ZRSR2 Specimen Requirement: 5 ml whole blood in an EDTA lavender top tube; Minimum: 1 ml; Diagnosis under consideration MUST be included with the sample; ANCAP Days Performed: Monday Friday NKFUNC Days Performed: Tuesday Friday Reported: 3 7 days ANCA Days Performed: Monday Friday PARVOG Days Performed: Tuesday, Friday Reported: 1 5 days PARVOM Days Performed: Tuesday, Friday Reported: 1 5 days ANCAC Days Performed: Monday Friday 7/14/2015 7/30/2015 7/2/2015 RPR RPR Days Performed: Sunday Saturday Reported: 1 2 days Synovial Fluid, Crystals ID and Staff Review Synovial Fluid, Routine Analysis SFCRID Specimen Requirement: 2 ml synovial fluid in an EDTA lavender top tube; Ambient *OR* 2 ml synovial fluid in a sodium or lithium heparin green top tube; Ambient RTSYNF 30 Specimen Requirement: 2 ml synovial fluid in an EDTA lavender top tube; Ambient *OR* 2 ml synovial fluid in a sodium or lithium heparin green top tube; Ambient 9/1/2015 9/1/ Euclid Avenue Cleveland, Ohio clevelandcliniclabs.com 6

7 Test Changes (Cont.) Test Name Order Code Billing Code Change Effective Date Thiocyanate THIOCY Reference Range: 5.0 mg/dl For nitroprusside therapy: mg/dl Nonsmokers: < 0.4 mg/dl Smokers: < 1.2 mg/dl Toxicity: > 5.0 mg/dl 9/22/2015 Urticaria-Induced Basophil Activation UTBAS Special Information: Reference Interval: Negative: 27 % Indeterminate (Borderline basophil activation detected): % Positive (Basophil activation detected): 39 % A value of 38 % suggests the presence of basophil stimulating antibodies (or other serum factors). Chronic urticaria (CU) is a common and complex dermatological condition that is suspected when patients experience persistent hives for over 6 weeks. No published evidence of an exogenous allergen as the cause of this disorder exists. About 45 % of cases have autoantibodies directed against either basophil or mast cell-associated IgE or the high affinity IgE-Fc receptor (Fc epsilon R1 alpha). The presence of histamine releasing factors (including but not limited to IgE and Fc epsilon R1 alpha-specific autoantibodies) in the patient serum can be indirectly determined by evaluating basophil/mast cell activation status using histamine release assays, autologous serum-skin test, and flow cytometric measurement of the basophil and mast-cell specific marker CD203c. Serum from CU patients can activate donor basophils, which induces histamine release and CD203c upregulation. Reference Range: 27% 7/16/2015 VIP VIP Special Information: VIP is a neurotransmitter and its excess can cause secretory diarrhea. VIP-secreting tumors are most commonly found in the tail of the pancreas in adults. VIP-producing ganglioneuromas or ganglioneuroblastomas may be found in the adrenal glands in children. CAUTION: This test should not be requested in patients who have recently received radioisotopes, therapeutically or diagnostically, because of potential assay interference. A recommended time period before collection cannot be made because it will depend on the isotope administered, the dose given and the clearance rate in the individual patient. Specimens will be screened for radioactivity prior to analysis. Radioactive samples received in the laboratory will be held and assayed after the radioactivity has sufficiently decayed. This will result in a test delay. Specimen Requirement: 1 ml plasma from an EDTA lavender top tube; Minimum: 0.6 ml; Eight hours fasting is required prior to specimen collection; Place specimen on ice after collection; Remove plasma from cells ASAP and freeze; Transport Frozen Ambient: Unacceptable : Unacceptable Frozen: 90 days Methodology: Radioimmunoassay (RIA) Reference Range: < 75 pg/ml Days Performed: Monday, Wednesday Reported: 4 9 days 7/30/ Euclid Avenue Cleveland, Ohio clevelandcliniclabs.com 7

8 Test Changes (Cont.) Test Name Order Code Billing Code Change Effective Date Y-Chromosome Microdeletion YCMICR For Interfaced Clients Only: Test build will need to be modified Special Information: Informed consent is required for patients living in New York state. Specimen MUST be received at performing laboratory within 4 days of collection. Clinical Information: Tests for microdeletions in the AZFa, AZFb and AZFc regions of the Y Chromosome. CAUTIONS: This assay will not detect all of the causes of infertility or azoospermia. Therefore, the absence of a detectable microdeletion(s) does not rule out the presence of other genetic or nongenetic factors that may be the cause of clinical findings. Rare polymorphisms exist that could lead to false-negative or false-positive results. If results obtained do not match the clinical findings, additional testing should be considered. In rare cases, DNA alterations of undetermined significance may be identified. A previous bone marrow transplant from an allogenic donor will interfere with testing. Specimen Requirement: 3 ml whole blood in an ACD A or B yellow top tube; Minimum: 0.5 ml; Send to Cleveland Clinic Laboratories on the day of collection; Ambient *OR* 3 ml whole blood in an EDTA lavender top tube; Minimum: 0.5 ml; Send to Cleveland Clinic Laboratories on the day of collection; Ambient New Tests Test Name Order Code Billing Code Test Information Effective Date Alpha Globin (HBA1 & HBA2) Sequencing HBA12B Specimen Requirement: 3 ml whole blood in an EDTA lavender top tube; Minimum: 1 ml; A completed ARUP 'Patient History for Hemoglobinopathy/Thalassemia Testing' form is required; The required form may be obtained by calling Client Services at or The form is also available at ltd.aruplab.com/tests/pdf/39; *OR* 100 µl extracted DNA at a concentration of 50 ng/µl; A completed ARUP 'Patient History for Hemoglobinopathy/ Thalassemia Testing' form is required; The required form may be obtained by calling Client Services at or The form is also available at com/tests/pdf/39; Ambient: 72 hours : 1 week Frozen: Unacceptable Methodology: Polymerase Chain Reaction, Sequencing Days Performed: Varies Reported: days CPT: Price: $ (non-discountable) 9/9/ Euclid Avenue Cleveland, Ohio clevelandcliniclabs.com 8

9 New Tests (Cont.) Test Name Order Code Billing Code Test Information Effective Date Anti-HMGCR Autoantibodies Beta Globin (HBB) Gene Sequencing FISH for RET (10q11) HMGCR Specimen Requirement: 2 ml serum from a serum separator tube; Minimum: 2 ml; *OR* 2 ml serum from a red top tube; Minimum: 2 ml; *OR* 2 ml plasma from an EDTA lavender top tube; Minimum: 2 ml; Ambient: 7 days : 2 3 weeks Frozen: 6 months Methodology: Enzyme Immunoassay (EIA) Reference Range: < 20 Unit Days Performed: Monday Friday Reported: 8 9 days CPT: Price: $ (non-discountable) BGHBBB Specimen Requirement: 3 ml whole blood in an EDTA lavender top tube; Minimum: 1 ml; A completed ARUP 'Patient History for Hemoglobinopathy/Thalassemia Testing' form is required; *OR* 3 ml whole blood in an ACD A or B yellow top tube; Minimum: 1 ml; A completed ARUP 'Patient History for Hemoglobinopathy/Thalassemia Testing' form is required; *OR* 100 µl extracted DNA at a concentration of 50 ng/µl; A completed ARUP 'Patient History for Hemoglobinopathy/ Thalassemia Testing' form is required; The required form may be obtained by calling Client Services at or The form is also available at Ambient: 72 hours : 1 week Frozen: Unacceptable Methodology: Polymerase Chain Reaction (PCR), Sequencing Days Performed: Varies Reported: days CPT: Price: $ (non-discountable) RET CPT: Price: $ (non-discountable) 8/13/2015 9/9/2015 GlycoMark GLYMRK Special Information: GlycoMark reference ranges apply to persons without diabetes. The GlycoMark test may be performed monthly on individuals with moderately controlled diabetes and HbA1c of 6 8 % to detect glucose excursions, and to monitor efficacy of therapy changes in diabetic individuals with high HbA1c (> 8%). CLINICAL SIGNIFICANCE: Measures 1,5 anhydroglucitol (1,5-AG), a glucose derived carbohydrate whose urinary excretion varies inversely with mean blood glucose. 1,5-AG appears to integrate variation in mean blood glucose over a period of about two weeks. Low circulating levels of 1,5-AG are associated with elevated levels of urinary albumin and N-acetylglucosaminidase, both markers of renal damage. (continued on page 10) 7/30/ Euclid Avenue Cleveland, Ohio clevelandcliniclabs.com 9

10 New Tests (Cont.) Test Name Order Code Billing Code Test Information Effective Date GlycoMark (continued from page 9) Methadone & Metabolites Nitrogen, Total, Feces Specimen Requirement: 1 ml serum from a serum separator tube; Minimum: 0.5 ml; *OR* 1 ml plasma from an EDTA lavender top tube; Minimum: 0.5 ml; *OR* 1 ml serum from a red top tube; Minimum: 0.5 ml; Ambient: Not acceptable : 7 days Frozen: > 7 days Methodology: Enzymatic Reference Range: Male: µg/ml Female: µg/ml Days Performed: Tuesday, Friday Reported: 2 7 days CPT: Price: $48.00 (non-discountable) MMTAB Includes: Methadone EDDP (2-ethylidene-1,5-dimethyl-3-3-diphenylpyrrolidine) Specimen Requirement: 0.5 ml serum in a red top tube; Ambient: 14 days : 14 days Frozen: 14 days Methodology: Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS) Reference Range: Not established Days Performed: Sunday Thursday Reported: 3 6 days CPT: Price: $78.00 (non-discountable) NITF Special Information: Send ENTIRE STOOL COLLECTION in a Mayo stool container (Supply T291). Include collection period and weight of entire collection with the sample. Call Cleveland Clinic Laboratories Client Services at or for stool containers. Specimen Requirement: 5 grams of stool in a 24, 48, 72, or 96 hour collection in a Mayo Stool collection container; Submit ENTIRE timed stool collection; Minimum: 2.5 grams; Frozen Ambient: 7 days : 7 days Frozen: 7 days Methodology: Dumas Combustion Reference Range: < 16 years: Not established 16 years: 1 2 g/24 hours Days Performed: Tuesday, Thursday Reported: 2 6 days CPT: Price: $ (non-discountable) 6/30/2015 8/27/ Euclid Avenue Cleveland, Ohio clevelandcliniclabs.com 10

11 New Tests (Cont.) Test Name Order Code Billing Code Test Information Effective Date Phospholipase A2 Receptor Antibody, IgG Retinal Dystrophy Panel PLA2R Special Information: If Phospholipase A2 Receptor Antibody, IgG is positive, then a Phospholipase Receptor A2 Antibody, IgG titer is reported. Additional charges apply. Specimen Requirement: 1 ml serum from a serum separator tube; Minimum: 0.2 ml; Remove serum from cells ASAP or within 2 hours of collection; *OR* 1 ml serum from a red top tube; Minimum: 0.2 ml; Remove serum from cells ASAP or within 2 hours of collection; Ambient: 2 days : 2 weeks Frozen: 1 year Methodology: Semi-Quantitative Indirect Fluorescent Antibody Reference Range: < 1:10 Days Performed: Wednesday Reported: 2 9 days CPT: Price: $ (non-discountable) RETDYS Includes: ABCA4, ABHD12, ADAM9, AIPL1, ALMSI, ASCC3L1/ SNRNP200, BBS1, BBS2, BBS3, BBS4, BBS5, BBS6, BBS7, BBS9, BBS10, BBS11, BBS12, BBS13/mks1, BBS15, BBS16, BBS17, BEST1, C1QTNF5, C2orf71, C8orf37, CA4, CABP4, CACNA2D4, CACNA1F, CDH23, CDHR1, CEP290/BBS14, CERKL, CHM, CLRN1, CNGA1, CNGA3, CNGB1, CNGB3, CNNM4, CRB1, CRX, DFNB31, DHDDS, ELOV4, EYS, FAM161A, FSCN2, GNAT1, GNAT2, GPR98, GPR179, GRK1, GRM6, GUCA1A, GUCA1B, GUCY2D, HARS, IDH3B, INPP5E, IMPDH1, IMPG2, IQCB1, KCNJ13, KCNV2, KLHL7, LCA5, LRAT, LRIT3, MAK, MERTK, MYO7A, NMNAT1, NR2E3, NRL, NYX, OFD1, OPA1, OPA3, OTX2, PCDH15, PDE6A, PDE6B, PDE6C, PDE6H, PDE6G, PDZD7, PITPNM3, PRCD, PROM1, PRPF3, PRPF6, PRPF8, PRPF31, RAX2, RBP3, RD3, RDH5, RDH12, RDS/PRPH2, RGR, RHO, RIMSI, RLBP1, ROM1, RP1, RP1L1, RP2, RP9, RPE65, RPGR, RPGRIP1, RS1, SAG, SEMA4A, SLC24A1, SPATA7, TOPORS, TRPM1, TTC8/BBS8, TULP1, USH1C, USHIG, USH1J-CIB2, UNC119, USH2A, ZNF513 Specimen Requirement: 4 ml whole blood in an EDTA lavender top tube; Minimum: 3 ml; Collect Monday Wednesday only. Send to Cleveland Clinic Laboratories on the day of collection. A signed, informed consent form and a completed CEI Molecular Diagnostics Lab requisition form are required with the specimen; Ambient *OR* 60 µg extracted DNA in a cryovial; Minimum: 10 µg; A signed, informed consent form and a completed CEI Molecular Diagnostics Lab requisition form are required with the specimen; Frozen Ambient: Whole blood: 5 days, Extracted DNA: Few weeks : Whole blood: 5 days, Extracted DNA: Few months Frozen: Whole blood: Unacceptable, Extracted DNA: Few years Available: Once in a lifetime Methodology: Next Gen Sequencing Polymerase Chain Reaction (PCR) Sanger Sequencing Amplification Days Performed: Twice a week Reported: 4 5 weeks CPT: Price: $ (non-discountable) 7/30/2015 7/30/ Euclid Avenue Cleveland, Ohio clevelandcliniclabs.com 11

12 New Tests (Cont.) Test Name Order Code Billing Code Test Information Effective Date Uveal Melanoma, Prognostic UVEAL Includes: GNAQ & GNA11 sequencing Microsatellite analysis on Chromosome 3 to detect chromosome copy loss and isodisomy Copy Number testing on Chromosomes 1p, 3, 6, and 8 to detect monosomy, disomy, and trisomy Specimen Requirement: THIS TEST REQUIRES MULTIPLE SPECIMEN TYPES: 10 ml whole blood in an ACD A or B yellow top tube; Ambient *OR* One cytology brush for buccal swab collection: 1) Gently rinse mouth with water 2) Scrape the inside of the patient's mouth using 10 strokes with one of the collection brushes in the kit. Either cheek is fine. 3) Cut handle from the collection brush using sterile scissors 4) Place brush in the collection tube in kit. 5) Label with patient's name and date of birth. 6) Briefly vortex to ensure sample is immersed in Cell Lysis Solution; *OR* 200 ng extracted DNA; *AND* Two fine need aspirates (FNA) in Qiagen Cell Lysis solution; *OR* Un-fixed, fresh or frozen tumor tissue biopsy in a sterile collection tube; Refrigerate/Freeze until ready to ship; Ship All samples should be transported in an Impact Genetics kit. Informed consent is required. Patient history, Specimen information, and Histology information are required. Kits are available through Impact Genetics ( ) or Cleveland Clinic Client Services at or Ambient: Whole blood: 2 weeks Buccal swab: 2 years in Cell Lysis Solution Tumor sample: 2 years in Cell Lysis Solution Extracted DNA: Not recommended : Whole blood: > 2 weeks Buccal swab: 2 years in Cell Lysis Solution Tumor sample: 2 years in Cell Lysis Solution Extracted DNA: 20 years Frozen: Whole blood: Unacceptable Buccal swab: Unacceptable Tumor sample: Undetermined Extracted DNA: Not recommended Methodology: Microsatellite Analysis (MSA) Multiplex-Ligation Probe Amplification (MLPA) Sequencing Days Performed: Monday Friday Reported: 4 7 weeks CPT: 81294, 81403x2, 81406, Price: $ (non-discountable) 8/6/ Euclid Avenue Cleveland, Ohio clevelandcliniclabs.com 12

13 Fee Increases Test Name Order Code Billing Code List Fee CPT Code Effective Date FISH for ROS1 (6q22) ROS $ (nondiscountable) Iron, Urine 24 hours UFE $99.00 (nondiscountable) /16/2015 Fee Reductions Test Name Order Code Billing Code List Fee CPT Code Effective Date Maternal Cell Contamination, Integrated Genetics MATRNL $ (nondiscountable) /30/2015 Vitamin D 25 Hydroxy VITD $ /14/2015 Discontinued Tests Test Name Order Code Billing Code Test Information Effective Date BCL 2 mbr (PCR) BCL This test will no longer be available 9/1/2015 HCV RNA bdna Quant with HCV Quant Reflex HCVQNT This test will no longer be available. Suggest ordering Hepatitis C RNA by PCR (HCQPCR) 7/1/2015 LOH for 1p (PCR) 1PPCRT This test will no longer be available 9/1/2015 LOH for 19q 19QPCT This test will no longer be available 9/1/2015 Methadone METHAD This test will no longer be available. Suggest ordering Methadone & Metabolites (MMTAB) 8/27/2015 PLA 1/2 by PCR PLAPCR This test will no longer be available 9/8/ Euclid Avenue Cleveland, Ohio clevelandcliniclabs.com 13

Variant prioritization

Variant prioritization Variant prioritization University of Cambridge Marta Bleda Latorre Cambridge, UK mb2033@cam.ac.uk 30th September 2014 Research Assistant at the Department of Medicine University of Cambridge Cambridge,

More information

UKGTN Testing Criteria

UKGTN Testing Criteria UKGTN Testing Criteria Approved name and symbol of disease/condition(s): Retinal Degeneration panel test Approved name and symbol of gene(s): a panel of 105 genes, variants of which have been shown to

More information

Supplementary appendix

Supplementary appendix Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Ellingford JM, Sergouniotis PI, Lennon R, et

More information

Variant association and prioritization

Variant association and prioritization Variant association and prioritization Edinburgh Genomics Marta Bleda Latorre Edinburgh, UK mb2033@cam.ac.uk 23rd October 2015 Research Assistant at the Department of Medicine University of Cambridge Cambridge,

More information

Phenotype Report. Num. Positions Not Called (Missing data) Num. Variants Assessed

Phenotype Report. Num. Positions Not Called (Missing data) Num. Variants Assessed Report Date: August 19, 2015 Software Annotation Version: 8 Report Name: NA12144 NW European Genome : NA12144_S1 Sequencing Provider: Illumina Sequencing Type: Exome : Retinitis Pigmentosa Description:

More information

The Center for PERSONALIZED DIAGNOSTICS

The Center for PERSONALIZED DIAGNOSTICS The Center for PERSONALIZED DIAGNOSTICS Precision Diagnostics for Personalized Medicine A joint initiative between The Department of Pathology and Laboratory Medicine & The Abramson Cancer Center The (CPD)

More information

Comprehensive genetic testing for hearing and vision loss

Comprehensive genetic testing for hearing and vision loss Comprehensive genetic testing for hearing and vision loss Hearing and vision loss can result from both genetic and non-genetic etiologies In general, there is a genetic basis for up to 50% of prelingual

More information

Address City State Zip Phone. the hospital/facility:

Address City State Zip Phone. the hospital/facility: PATIENT INFORMATION (COMPLETE ONE FORM FOR EACH PERSON TESTED) Patient Last Name Patient First Name MI Date of Birth (MM / DD / YYYY) Address City State Zip Phone Patient discharged from Biological Sex:

More information

Out-Patient Billing CPT Codes

Out-Patient Billing CPT Codes Out-Patient Billing CPT Codes Updated Date: August 3, 08 Client Billed Molecular Tests HPV DNA Tissue Testing 8764 No Medicare Billed - Molecular Tests NeoARRAY NeoARRAY SNP/Cytogenetic No 89 NeoLAB NeoLAB

More information

Next Generation Sequencing in Haematological Malignancy: A European Perspective. Wolfgang Kern, Munich Leukemia Laboratory

Next Generation Sequencing in Haematological Malignancy: A European Perspective. Wolfgang Kern, Munich Leukemia Laboratory Next Generation Sequencing in Haematological Malignancy: A European Perspective Wolfgang Kern, Munich Leukemia Laboratory Diagnostic Methods Cytomorphology Cytogenetics Immunophenotype Histology FISH Molecular

More information

NeoTYPE Cancer Profiles

NeoTYPE Cancer Profiles NeoTYPE Cancer Profiles Multimethod Analysis of 25+ Hematologic Diseases and Solid Tumors Anatomic Pathology FISH Molecular The next generation of diagnostic, prognostic, and therapeutic assessment NeoTYPE

More information

Illumina Trusight Myeloid Panel validation A R FHAN R A FIQ

Illumina Trusight Myeloid Panel validation A R FHAN R A FIQ Illumina Trusight Myeloid Panel validation A R FHAN R A FIQ G E NETIC T E CHNOLOGIST MEDICAL G E NETICS, CARDIFF To Cover Background to the project Choice of panel Validation process Genes on panel, Protocol

More information

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier/Additional Provider

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier/Additional Provider Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier/Additional Provider TEST DISEASE/CONDITION POPULATION TRIAD Submitting laboratory: 1. Disease/condition approved name and

More information

NeoTYPE Cancer Profiles

NeoTYPE Cancer Profiles NeoTYPE Cancer Profiles 30+ Multimethod Assays for Hematologic Diseases and Solid Tumors Molecular FISH Anatomic Pathology The next generation of diagnostic, prognostic, and therapeutic assessment What

More information

Retinal dystrophies, genomic applications in diagnosis and prospects for therapy

Retinal dystrophies, genomic applications in diagnosis and prospects for therapy Review Article Retinal dystrophies, genomic applications in diagnosis and prospects for therapy Benjamin M. Nash 1,2,3, Dale C. Wright 2,3, John R. Grigg 1, Bruce Bennetts 2,3, Robyn V. Jamieson 1,3 1

More information

Genetic Defect Underlying Progressive Blindness Uncovered by Strand s Clinical Exome Test

Genetic Defect Underlying Progressive Blindness Uncovered by Strand s Clinical Exome Test CASE STUDY Genetic Defect Underlying Progressive Blindness Uncovered by Strand s Clinical Exome Test Patient Profile Swati Koparkar*, a 33-year-old owner of a handicrafts boutique had been experiencing

More information

Interpath Laboratory, Inc. Test File Update

Interpath Laboratory, Inc. Test File Update As an Interpath customer who receives electronic results or sends electronic orders you may need to be notified when we update our Service Manual. Although we try to keep these changes to a minimum, laboratory

More information

August 17, Dear Valued Client:

August 17, Dear Valued Client: August 7, 08 Re: CMS Announces 6-Month Period of Enforcement Discretion for Laboratory Date of Service Exception Policy Under the Medicare Clinical Laboratory Fee Schedule (the 4 Day Rule ) Dear Valued

More information

27027 Tourney Road Valencia, CA 91355 800 421 7110 www.specialtylabs.com Test Updates November 26, 2008 Dear Colleague: We are pleased to announce the availability of two new assays for an expanded evaluation

More information

Cleveland Clinic Laboratories

Cleveland Clinic Laboratories Cleveland Clinic Laboratories Technical Update September 2012 Cleveland Clinic Laboratories is dedicated to keeping you updated and informed about recent testing changes. That's why we are happy to provide

More information

Cleveland Clinic Laboratories

Cleveland Clinic Laboratories Cleveland Clinic Laboratories Technical Update January 2019 Cleveland Clinic Laboratories is dedicated to keeping you updated and informed about recent testing changes. This Technical Update is provided

More information

Laboratory Service Report

Laboratory Service Report Client C7028846-DLP Rochester Rochester, N 55901 Specimen Type Peripheral blood CR PDF Report available at: https://test.mmlaccess.com/reports/c7028846-zwselwql7p.ashx Indication for Test DS CR Pathogenic

More information

July Monthly Update, Quest Diagnostics Nichols Institute, Valencia

July Monthly Update, Quest Diagnostics Nichols Institute, Valencia NEW TESTS Please Note: Not all test codes assigned to each assay are listed in the table of contents. Please refer to the complete listing on the page numbers indicated. Test Name Effective Date Page #

More information

Molecular. Oncology & Pathology. Diagnostic, Prognostic, Therapeutic, and Predisposition Tests in Precision Medicine. Liquid Biopsy.

Molecular. Oncology & Pathology. Diagnostic, Prognostic, Therapeutic, and Predisposition Tests in Precision Medicine. Liquid Biopsy. Molecular Oncology & Pathology Hereditary Cancer Somatic Cancer Liquid Biopsy Next-Gen Sequencing qpcr Sanger Sequencing Diagnostic, Prognostic, Therapeutic, and Predisposition Tests in Precision Medicine

More information

March Monthly Update, Quest Diagnostics Nichols Institute, Valencia

March Monthly Update, Quest Diagnostics Nichols Institute, Valencia NEW TESTS Please Note: Not all test codes assigned to each assay are listed in the table of contents. Please refer to the complete listing on the page numbers indicated. Test Code Test Name Effective Date

More information

27027 Tourney Road Valencia, CA 91355 800 421 7110 www.specialtylabs.com Test Updates September 25, 2009 Dear Colleague: Specialty Laboratories is pleased to announce a new assay, PT and PTT-LA Mixing

More information

Cleveland Clinic Laboratories

Cleveland Clinic Laboratories Cleveland Clinic Laboratories Technical Update February 2016 Cleveland Clinic Laboratories is dedicated to keeping you updated and informed about recent testing changes. That s why we are happy to provide

More information

Cleveland Clinic Laboratories

Cleveland Clinic Laboratories Cleveland Clinic Laboratories Technical Update July 2016 Cleveland Clinic Laboratories is dedicated to keeping you updated and informed about recent testing changes. That s why we are happy to provide

More information

Next generation sequencing analysis - A UK perspective. Nicholas Lea

Next generation sequencing analysis - A UK perspective. Nicholas Lea Next generation sequencing analysis - A UK perspective Nicholas Lea King s HMDC LMH is part of an integrated pathology service at King s Haematological Malignancy Diagnostic Centre (HMDC) HMDC serves population

More information

TEST MENU TEST CPT CODES TAT. Chromosome Analysis Bone Marrow x 2, 88264, x 3, Days

TEST MENU TEST CPT CODES TAT. Chromosome Analysis Bone Marrow x 2, 88264, x 3, Days TEST MENU CANCER/LEUKEMIA CHROMOSOME ANALYSIS Chromosome Analysis Bone Marrow 88237 x 2, 88264, 88280 x 3, 88291 4 Days Chromosome Analysis Bone Marrow Core 88237 x 2, 88264, 88280 x 3, 88291 4 Days Chromosome

More information

March Immunoglobulins, Total (IgA, IgE, IgG, IgM) Interleukin-6 (IL6) Protein Electrophoresis, CSF. Thyrotropin Receptor Antibody

March Immunoglobulins, Total (IgA, IgE, IgG, IgM) Interleukin-6 (IL6) Protein Electrophoresis, CSF. Thyrotropin Receptor Antibody University of Washington March 2012 TEST CHANGE Alpha 1-Antitrypsin Anti-IgE Receptor Antibody Anti-Mullerian Hormone Aquaporin-4 Receptor Antibody ColoSeq - Polyposis Complement testing, C3, C4 Everolimus

More information

EXT ADDRESS CITY LAST NAME ID NUMBER PT. ADDRESS CITY INSURANCE PROVIDER. 0 Other. 0 IGH/B-cell cionaliry (PCR)

EXT ADDRESS CITY LAST NAME ID NUMBER PT. ADDRESS CITY INSURANCE PROVIDER. 0 Other. 0 IGH/B-cell cionaliry (PCR) THE UNIVERSITY OF TEXAS *Required Fields PHYSICIAN! FACILITY/ CLIENT INFORMATION MDAndersonefief &ter MaltgararEettcy 'REQUESTING PHYSICIAN Division of Pathology! Laboratory Medicine Services Test Requisition

More information

Anti-FceR (CU Index) Antibody

Anti-FceR (CU Index) Antibody Anti-FceR (CU Index) Antibody Order Name: ANTI-FCER Test Number: 5587500 REV DATE:5/31/2007 Anti-FceR (CU Index) Antibody CU Index Preferred 2 ml (1mL) Serum Clot Activator SST (Red/Gray or Tiger Top)

More information

INTERPATH LABORATORY, INC. TEST UPDATES

INTERPATH LABORATORY, INC. TEST UPDATES EFFECTIVE DATE: February 16, 2016 INTERPATH LABORATORY, INC. TEST UPDATES Please take note of the following test updates and make the appropriate changes in your Interpath Service Manual. Feel free to

More information

In-Common Laboratories

In-Common Laboratories Stability Information: Specimen stability information has been added or revised for the following tests: Vitamin B6, Dehydroepiandrosterone, Thyroid Antibodies (Thyroid Peroxidase Ab & Thyroglobulin Ab)

More information

Introduction of an NGS gene panel into the Haemato-Oncology MPN service

Introduction of an NGS gene panel into the Haemato-Oncology MPN service Introduction of an NGS gene panel into the Haemato-Oncology MPN service Dr. Anna Skowronska, Dr Jane Bryon, Dr Samuel Clokie, Dr Yvonne Wallis and Professor Mike Griffiths West Midlands Regional Genetics

More information

12/10/ Immediate Action, Quest Diagnostics Nichols Institute, Valencia

12/10/ Immediate Action, Quest Diagnostics Nichols Institute, Valencia NEW TESTS Please Note: Not all test codes assigned to each assay are listed in the table of contents. Please refer to the complete listing on the page numbers indicated. Test Code Test Name Effective Date

More information

Supplementary Information

Supplementary Information Supplementary Information Table of Contents Supplementary methods... 2 Figure S1 - Variable DNA yield proportional to bone marrow aspirate cellularity.... 3 Figure S2 - Mutations by clinical ontogeny group....

More information

TEST REQUEST INFORMATION- VIROLOGY

TEST REQUEST INFORMATION- VIROLOGY Chlamydia/ Gonorrhea Nucleic Acid Amplification VC75 Qualitative Nucleic Acid Amplification SPECIMEN: Genital swab or first catch urine CONTAINER:GEN-PROBE APTIMA 2 Combo swab transport tube or urine transport

More information

October Courier Service on Holidays There will be no courier service Thursday, Dec. 24th, 2011.

October Courier Service on Holidays There will be no courier service Thursday, Dec. 24th, 2011. University of Washington October 2011 TEST CHANGE ACTH Aldosterone BCR/ABL by PCR, Qualitative Chlamydia trachomatis & N.gonorrhoeae, Amp. NA Creutzfeldt-Jakob, CSF Desipramine Doxepine and Nordoxepine,

More information

Select analysis on the next pages. Sample request and sending address see last page. Institut für Pathologie und Molekularpathologie

Select analysis on the next pages. Sample request and sending address see last page. Institut für Pathologie und Molekularpathologie Diagnostic Tumor Genome Analysis Schmelzbergstrasse 12 8091 Zürich Tel.: (+41) 044 255 3929 Fax.: (+41) 044 255 4416 Client (address, telephone number): ngs.pathologie@usz.ch www.pathologie.usz.ch Sample-Nr:

More information

H. PYLORI AB, IGG HPYL

H. PYLORI AB, IGG HPYL H. PYLORI AB, IGG HPYL Specimen Required: 3 ml blood, Serum gel tube Analytical Time: 1 day CPT Code: 86677 HAPTOGLOBIN HAP Specimen Required: 1.5 ml blood, gel tube Reference Range: 30-200 mg/dl CPT Code:

More information

Date of Birth Gender Ethnicity/Family History Male Female Unknown. (Institutional Billing only. We DO NOT bill patients directly.)

Date of Birth Gender Ethnicity/Family History Male Female Unknown. (Institutional Billing only. We DO NOT bill patients directly.) PATIENT INFORMATION Last Name First M.I. CLINICAL LABORATORY Date of Birth Gender Ethnicity/Family History Male Female Unknown Molecular Diagnotics Patient or Sample ID# Institutional Account # (415) 514-8488

More information

October Billing and compliance. Coagulation. Immunohistochemistry. Immunology. Referral testing ICD 10

October Billing and compliance. Coagulation. Immunohistochemistry. Immunology. Referral testing ICD 10 October 2015 Billing and compliance ICD 10 Coagulation Processing, transport and stability changes for multiple coagulation tests Immunohistochemistry IHC stain updates Immunology Lyme Western Blot testing

More information

TEST LIST SAMPLE REQUIREMENT. 1 ml serum None

TEST LIST SAMPLE REQUIREMENT. 1 ml serum None ALBUMIN TEST NAME ALKALINE PHOSPHATASE ALLERGY PROFILE, FOOD 30 allergens ALLERGY PROFILE, INHALANT 30 Allergens ALT AMYLASE ANA ANTI- TG ANTI-GLIADIN IGG ANTI-GLIADIN IGA ANTI-HBS ANTI-HCV ANTI-TPO APOLIPOPROTEIN

More information

7/12/2016 TESTING. Objectives. New Directions in Aplastic Anemia: What's on the Horizon? Better way to evaluate clonal evolution?

7/12/2016 TESTING. Objectives. New Directions in Aplastic Anemia: What's on the Horizon? Better way to evaluate clonal evolution? New Directions in Aplastic Anemia: What's on the Horizon? Amy E. DeZern, MD; MHS Assistant Professor Hematologic Malignancies Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, MD Objectives

More information

Laboratory Service Report

Laboratory Service Report Specimen Type Peripheral blood CR PDF Report available at: https://test.mmlaccess.com/reports/c7028846-ih2xuglwpq.ashx Indication for Test DS CR Pathogenic utations Detected CR 1. JAK2: c.1849g>t;p.val617phe

More information

Specimen Collection Requirements. Test Name Specimen Type Storage Time Storage Conditions

Specimen Collection Requirements. Test Name Specimen Type Storage Time Storage Conditions 1 Specimen Collection Requirements PURPOSE/PRINCIPLE: To outline proper specimen collection for molecular HLA testing, including tube type, minimum specimen amount, proper tube and requisition labeling,

More information

Acetylcholine Receptor Binding Antibody

Acetylcholine Receptor Binding Antibody Acetylcholine Receptor Binding Antibody Order Name: ACETY BND Test Number: 5500010 REV DATE:9/17/2008 Acetylcholine Receptor Binding Antibody RIA Preferred 1 ml (0.5) Serum Clot Activator (Red Top, No-Gel)

More information

IMMEDIATE HOT LINE: Effective January 6, 2014

IMMEDIATE HOT LINE: Effective January 6, 2014 MEDICARE COVERAGE OF LABORATORY TESTING Please remember when ordering laboratory tests that are billed to Medicare/Medicaid or other federally funded programs, the following requirements apply: 1. Only

More information

Providence Medford Medical Center Pathology Department

Providence Medford Medical Center Pathology Department Providence Medford Medical Center Pathology Department Anatomic pathology services including histology, cytology and autopsies are offered through Providence Medford Medical Center Pathology Department.

More information

Business Unit: Quest Diagnostics Nichols Institute, Valencia. June 2011 Update Dear Colleague,

Business Unit: Quest Diagnostics Nichols Institute, Valencia. June 2011 Update Dear Colleague, Volume 2 Apr/2011 Business Unit: June 2011 Update Dear Colleague, This letter begins with a thank you for your very prompt response to our recent request to visit our website and update your contact information.

More information

March Molecular diagnostics. Update distribution changes. Billing and compliance. Hematology. Immunology. Referral testing

March Molecular diagnostics. Update distribution changes. Billing and compliance. Hematology. Immunology. Referral testing March 2016 Update distribution changes Billing and compliance Compliance Drug Analysis CPT change Hematology Hemoglobin A1c, Screening Reference Range Change Immunology Testing schedule changes Vitamin

More information

December Metanephrines, Fractionated, Free, Plasma Plasminogen Activator Inhibitor Type 1 Stool Cultures and Sensitivities

December Metanephrines, Fractionated, Free, Plasma Plasminogen Activator Inhibitor Type 1 Stool Cultures and Sensitivities University of Washington December 2012 TEST change 1,25 Dihydroxy Vitamin D Frequency AFB Blood Cultures Alcohol Screen Anti Deaminated Gliadin, IgG Anti Gliadin Package Anti Mullerian Hormone Package

More information

27027 Tourney Road Valencia, CA 91355 800 421 7110 www.specialtylabs.com Test Updates July 27, 2009 Dear Colleague: As we prepare for the upcoming flu season, Specialty Laboratories clients should be aware

More information

한국인망막색소변성증환자에서발견한복합이형접합 EYS 변이 1 예보고

한국인망막색소변성증환자에서발견한복합이형접합 EYS 변이 1 예보고 편지 Lab Med Online Vol. 8, No. 2: 66-70, April 2018 진단유전학 한국인망막색소변성증환자에서발견한복합이형접합 EYS 변이 1 예보고 Identification of Compound Heterozygous EYS Variants in a Korean Patient with Retinitis Pigmentosa 김형태 1 장자현

More information

June Monthly Update, Quest Diagnostics Nichols Institute, Valencia

June Monthly Update, Quest Diagnostics Nichols Institute, Valencia June 2013 - Monthly Update, NEW TESTS Please Note: Not all test codes assigned to each assay are listed in the table of contents. Please refer to the complete listing on the page numbers indicated. Test

More information

Please Silence Your Cell Phones. Thank You

Please Silence Your Cell Phones. Thank You Please Silence Your Cell Phones Thank You Utility of NGS and Comprehensive Genomic Profiling in Hematopathology Practice Maria E. Arcila M.D. Memorial Sloan Kettering Cancer Center New York, NY Disclosure

More information

Examining Genetics and Genomics of Acute Myeloid Leukemia in 2017

Examining Genetics and Genomics of Acute Myeloid Leukemia in 2017 Examining Genetics and Genomics of Acute Myeloid Leukemia in 2017 Elli Papaemmanuil, PhD Memorial Sloan Kettering Cancer Center New York, New York, United States Today s Talk Cancer genome introduction

More information

Blastic Plasmacytoid Dendritic Cell Neoplasm with DNMT3A and TET2 mutations (SH )

Blastic Plasmacytoid Dendritic Cell Neoplasm with DNMT3A and TET2 mutations (SH ) Blastic Plasmacytoid Dendritic Cell Neoplasm with DNMT3A and TET2 mutations (SH2017-0314) Habibe Kurt, Joseph D. Khoury, Carlos E. Bueso-Ramos, Jeffrey L. Jorgensen, Guilin Tang, L. Jeffrey Medeiros, and

More information

Cleveland Clinic Laboratories

Cleveland Clinic Laboratories Cleveland Clinic Laboratories Technical Update October 2017 Cleveland Clinic Laboratories is dedicated to keeping you updated and informed about recent testing changes. This Technical Update is provided

More information

The preclinical efficacy of a novel telomerase inhibitor, imetelstat, in AML: A randomized trial in patient-derived xenografts

The preclinical efficacy of a novel telomerase inhibitor, imetelstat, in AML: A randomized trial in patient-derived xenografts The preclinical efficacy of a novel telomerase inhibitor, imetelstat, in AML: A randomized trial in patient-derived xenografts Claudia Bruedigam, Ph.D Gordon and Jessie Gilmour Leukaemia Research Laboratory

More information

Aerobic Wound Culture and Stain

Aerobic Wound Culture and Stain Aerobic Wound Culture and Stain Order Name: C WOUN RTS Test Number: 6000153 Revision Date: 03/27/2014 Aerobic Wound Culture and Stain Culture Preferred 1 ml Tissue Sterile Screwtop Container Room Temperature

More information

METABOLITE TEST REQUISITION FORM SPECIMEN INFORMATION. Specimen Date: Time: ADDITIONAL INFORMATION

METABOLITE TEST REQUISITION FORM SPECIMEN INFORMATION. Specimen Date: Time: ADDITIONAL INFORMATION METABOLITE TEST REQUISITION FORM Baylor Institute of Metabolic Disease Last Name: First Name: DOB/Age: Gender: Male Female Medical Record #/Patient ID #: PATIENT INFORMATION - OR Place Patient Sticker

More information

Testing for Fabry Disease. What You Need to Know

Testing for Fabry Disease. What You Need to Know Testing for Fabry Disease What You Need to Know Identification of One Family Member Can Enable Earlier Screening for Others A woman with Fabry disease may have inherited it from either her mother or her

More information

Cleveland Clinic Laboratories

Cleveland Clinic Laboratories Cleveland Clinic Laboratories Technical Update September 2017 Cleveland Clinic Laboratories is dedicated to keeping you updated and informed about recent testing changes. This Technical Update is provided

More information

Genetics and the Macular Dystrophies. George Anadiotis D.O. Medical Director Clinical and Biochemical Genetics Randall Children s Hospital

Genetics and the Macular Dystrophies. George Anadiotis D.O. Medical Director Clinical and Biochemical Genetics Randall Children s Hospital Genetics and the Macular Dystrophies George Anadiotis D.O. Medical Director Clinical and Biochemical Genetics Randall Children s Hospital Stargardt disease Best Vitelliform Macular Dystrophy North Carolina

More information

METABOLITE TEST REQUISITION FORM

METABOLITE TEST REQUISITION FORM METABOLITE TEST REQUISITION FORM Baylor Scott and White Research Institute Last Name: First Name: DOB/Age: Gender: Male Female Medical Record #/Patient ID #: PATIENT INFORMATION OR Place Patient Sticker

More information

West Midlands Regional Genetics Laboratory

West Midlands Regional Genetics Laboratory West Midlands Regional Genetics Laboratory Haemato-oncology service update letter October 2017 Dear colleagues, We are writing to outline the latest developments to our service, aiming to support the management

More information

ADRL Advanced Diagnostics Research Laboratory

ADRL Advanced Diagnostics Research Laboratory ADRL Advanced Diagnostics Research Laboratory John DeCoteau, MD FRCP Department of Pathology, Division of Hematopathology University of Saskatchewan Saskatchewan Cancer Agency ADRL Project Objectives New

More information

Cleveland Clinic Laboratories

Cleveland Clinic Laboratories Cleveland Clinic Laboratories Technical Update June 2015 Cleveland Clinic Laboratories is dedicated to keeping you updated and informed about recent testing changes. That s why we are happy to provide

More information

Interpath Laboratory, Inc. Test File Update

Interpath Laboratory, Inc. Test File Update As an Interpath customer who receives electronic results or sends electronic orders you may need to be notified when we update our Service Manual. Although we try to keep these changes to a minimum, laboratory

More information

Objectives. Morphology and IHC. Flow and Cyto FISH. Testing for Heme Malignancies 3/20/2013

Objectives. Morphology and IHC. Flow and Cyto FISH. Testing for Heme Malignancies 3/20/2013 Molecular Markers in Hematologic Malignancy: Ways to locate the needle in the haystack. Objectives Review the types of testing for hematologic malignancies Understand rationale for molecular testing Marcie

More information

All abnormal results for this test will automatically have the DNA test reflexed at an additional cost.

All abnormal results for this test will automatically have the DNA test reflexed at an additional cost. 2211 Michigan Avenue Santa Monica, CA 90404 800 421 4449 Dear Colleague: May-June 2004 REVISED 6-15-04 At Specialty we continue to focus on working with you to reduce the problems that can result in tests

More information

SERVICE SCHEDULE, FEES & GUIDELINES FOR SAMPLE SHIPMENT

SERVICE SCHEDULE, FEES & GUIDELINES FOR SAMPLE SHIPMENT SERVICE SCHEDULE, FEES & GUIDELINES FOR SAMPLE SHIPMENT ACYLCARNITINE PROFILE: PLASMA/SERUM, PKU CARD, WHOLE BLOOD Amount of sample: Plasma (heparinized is preferred, EDTA acceptable) or serum: 0.5 ml

More information

Next generation sequencing identified novel heterozygous nonsense mutation in CNGB1 gene associated with retinitis pigmentosa in a Chinese patient

Next generation sequencing identified novel heterozygous nonsense mutation in CNGB1 gene associated with retinitis pigmentosa in a Chinese patient /, 2017, Vol. 8, (No.51), pp: 88345-88350 Next generation sequencing identified novel heterozygous nonsense mutation in CNGB1 gene associated with retinitis pigmentosa in a Chinese patient Santasree Banerjee

More information

27027 Tourney Road Valencia, CA 91355 800 421 7110 www.specialtylabs.com Test Updates November 25, 2010 Dear Colleague: This client letter contains many changes to our reference ranges in the area of chemistry

More information

Patricia Aoun MD, MPH Professor and Vice-Chair for Clinical Affairs Medical Director, Clinical Laboratories Department of Pathology City of Hope

Patricia Aoun MD, MPH Professor and Vice-Chair for Clinical Affairs Medical Director, Clinical Laboratories Department of Pathology City of Hope Patricia Aoun MD, MPH Professor and Vice-Chair for Clinical Affairs Medical Director, Clinical Laboratories Department of Pathology City of Hope National Medical Center Disclosures I have no disclosures

More information

HML Update. Summer 2009 Volume 15, No. 3. Keeping Our Clients Informed Questions or Comments: Call

HML Update.  Summer 2009 Volume 15, No. 3. Keeping Our Clients Informed Questions or Comments: Call HML Update Summer 2009 Volume 15, No. 3 Keeping Our Clients Informed Questions or Comments: Call 651-232-3500 Inside: Panel Changes...1-2 New Panels...2-3 H1N1... 3 Note of Appreciation... 3 BD Vacutainer

More information

Patient Preparation Unique patient preparation requirements are listed under each test in the Test Directory.

Patient Preparation Unique patient preparation requirements are listed under each test in the Test Directory. Specimen Collection Lab results are only as good as the specimen provided. Patient preparation, venipuncture technique, specimen handling, and transportation can all affect the quantity of results. Health

More information

Prices listed correspond to institutional rates only; please contact the lab for insurance rates.

Prices listed correspond to institutional rates only; please contact the lab for insurance rates. Prices listed correspond to institutional rates only; please contact the lab for insurance rates. Genetic Test TAT ** Neurofibromatosis Type 1 - NF1 and Legius syndrome SPRED1 $1400 (NF1/SPRED1 negative)

More information

Cleveland Clinic Laboratories

Cleveland Clinic Laboratories Cleveland Clinic Laboratories Technical Update May 2018 Cleveland Clinic Laboratories is dedicated to keeping you updated and informed about recent testing changes. This Technical Update is provided on

More information

Comprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS

Comprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS Comprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS NF1/SPRED1 and Other RASopathy Related Conditions NF1 only NGS testing and copy number analysis for the NF1 gene (NF1

More information

Basic Metabolic Panel

Basic Metabolic Panel Basic Metabolic Panel Order Name: CHEM 8 Test Number: 2028100 REV DATE:2/5/2008 Glucose Urea Nitrogen, Blood (BUN) Creatinine Sodium Potassium Serum/Plasma Chloride Bicarbonate Calcium Anion Gap Calculated

More information

IntelliGENSM. Integrated Oncology is making next generation sequencing faster and more accessible to the oncology community.

IntelliGENSM. Integrated Oncology is making next generation sequencing faster and more accessible to the oncology community. IntelliGENSM Integrated Oncology is making next generation sequencing faster and more accessible to the oncology community. NGS TRANSFORMS GENOMIC TESTING Background Cancers may emerge as a result of somatically

More information

Interpath Laboratory, Inc. Test File Update

Interpath Laboratory, Inc. Test File Update As an Interpath customer who receives electronic results or sends electronic orders you may need to be notified when we update our Service Manual. Although we try to keep these changes to a minimum, laboratory

More information

Alkaline Phosphatase, Bone Specific

Alkaline Phosphatase, Bone Specific Alkaline Phosphatase, Bone Specific Order Name: ALK P BONE Test Number: 3656500 REV DATE:11/5/2010 Alkaline Phosphatase, Bone Specific IMMENZ Preferred 1 ml (0.3) Serum Clot Activator SST (Red/Gray or

More information

Tests that have had changes to the method/ CPT code, units of measurement, scope of analysis, reference comments, or specimen requirements.

Tests that have had changes to the method/ CPT code, units of measurement, scope of analysis, reference comments, or specimen requirements. Immediate Action In our continuing effort to provide you with the highest quality toxicology laboratory services available, we have compiled important changes regarding a number of tests we perform. Listed

More information

Pathology Specimen Handling Requirements

Pathology Specimen Handling Requirements CONWAY REGIONAL HEALTH SYSTEM CLINICAL LABORATORY Pathology Specimen Handling Requirements POLICY: Tissue or body fluids, etc. removed or collected during any procedure for purposes of Pathologist examination

More information

Drugs of Abuse Confirmation/Quantitation - Opiates - Urine CDCO OPI 211

Drugs of Abuse Confirmation/Quantitation - Opiates - Urine CDCO OPI 211 ARUP Standard Transport Tube. (Min: 2 ml) Unacceptable Conditions: Separator tubes. Plasma or whole blood collected in lt. blue (sodium citrate). Specimens exposed to repeated freeze/thaw cycles. Stability:

More information

We re here to help! Member Services. Foundations of Functional Blood Chemistry Analysis Session 1 Doctor s Choice Presentation

We re here to help! Member Services. Foundations of Functional Blood Chemistry Analysis Session 1 Doctor s Choice Presentation Doctor s Choice is a professional health care organization offering licensed health care professionals an easy and convenient way to get discounted laboratory tests. Whether you have a low volume or a

More information

The Evolving Role of Transplantation for MPN

The Evolving Role of Transplantation for MPN The Evolving Role of Transplantation for MPN (PMF, PV, ET) H.Joachim Deeg MD Fred Hutchinson Cancer Research Center, University of Washington, Seattle WA, SCCA jdeeg@fhcrc.org 10 th J. Niblack Conference

More information

SESSION 1 Reactive cytopenia and dysplasia

SESSION 1 Reactive cytopenia and dysplasia SESSION 1 Reactive cytopenia and dysplasia Falko Fend, Tübingen & Alexandar Tzankov, Basel 1 Disclosure of speaker s interests (Potential) conflict of interest none Potentially relevant company relationships

More information

Please contact Customer Service with any questions. Ph: option 5

Please contact Customer Service with any questions. Ph: option 5 Sarasota Memorial Laboratory Services is pleased to announce that we are now performing the following testing in house: Immature Platelet Fraction (IPF) The Immature Platelet Fraction (IPF) is used to

More information

Alaska Native Medical Center Anchorage, AK

Alaska Native Medical Center Anchorage, AK ANMC Lab Test Requirements Key: Room Temp (20-25C), Refrigerated (2-8C), (-15 to -25C), Hr (Hours), D (Days), W (Weeks), Mo (Months), Yr (Years). Basic Processing Instructions: Centrifuge all blood specimens

More information

TELEFAX. Toxoplasma Serology Laboratory (TSL) DATE: TO: FAX: FROM:

TELEFAX. Toxoplasma Serology Laboratory (TSL) DATE: TO: FAX: FROM: TELEFAX DATE: TO: FAX: FROM: Toxoplasma Serology Laboratory RE: SPECIMEN REQUIREMENTS AND TESTING INFORMATION (effective 1/15/16) THIS TRANSMISSION CONSISTS OF 16 PAGES INCLUDING THIS COVER PAGE. IF THERE

More information

New Test Announcements

New Test Announcements 27027 Tourney Road Valencia, CA 91355 800 421 7110 www.specialtylabs.com New Test Announcements Dear Colleague: We are pleased to announce many new test offerings this month. January 25, 2007 In oncology,

More information

MICROBIOLOGY SPECIMEN COLLECTION MANUAL

MICROBIOLOGY SPECIMEN COLLECTION MANUAL Lee Memorial Health System Lee County, FL CLINICAL LABORATORY MICROBIOLOGY SPECIMEN COLLECTION MANUAL ACID FAST CULTURE Specimen Type see Specimen Chart ACID FAST STAIN see Specimen Chart Acid Fast stain

More information

Prices listed correspond to institutional rates only; please contact the lab for insurance rates.

Prices listed correspond to institutional rates only; please contact the lab for insurance rates. Prices listed correspond to institutional rates only; please contact the lab for insurance rates. Genetic Test Neurofibromatosis Type 1 - NF1 and Legius syndrome SPRED1 $1400 (NF1/SPRED1 negative) 81408,

More information